| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C10AX16 | B | Inclisiran - 284mg/1.5ml | 12603 | 20921/1 | LEQVIO | 284mg/1.5ml | 1x1.5ml | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharmaceutical Manufacturing GmbH | Austria | 218,123,272 L.L | 2.44 | E2 | Novartis Europharm Limited | Ireland | 6/3/2026 |

